CG Oncology
CGON
CGON
140 hedge funds and large institutions have $1.9B invested in CG Oncology in 2024 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 59 increasing their positions, 27 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
10.58% more ownership
Funds ownership: 77.79% → 88.38% (+11%)
9% more funds holding in top 10
Funds holding in top 10: 11 → 12 (+1)
3% less capital invested
Capital invested by funds: $1.96B → $1.9B (-$67.1M)
Holders
140
Holding in Top 10
12
Calls
$6.49M
Puts
$1.03M
Top Buyers
| 1 | +$65.6M | |
| 2 | +$41.6M | |
| 3 | +$40.2M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$26.6M |
| 5 |
DC
Decheng Capital
Menlo Park,
California
|
+$25.6M |
Top Sellers
| 1 | -$52.7M | |
| 2 | -$37.5M | |
| 3 | -$16M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12.6M |
| 5 |
PA
Perceptive Advisors
New York
|
-$9.01M |